<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05615246</url>
  </required_header>
  <id_info>
    <org_study_id>CR18-001</org_study_id>
    <nct_id>NCT05615246</nct_id>
  </id_info>
  <brief_title>Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty PMCF (HRP)</brief_title>
  <acronym>HRP</acronym>
  <official_title>An Open Label, Multi-Center, Retrospective and Prospective Evaluation of Exactech Humeral Reconstruction Prosthesis of Shoulder Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Exactech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Exactech</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to collect and evaluate long-term clinical outcomes data in&#xD;
      order to better understand the safety and performance of the Equinoxe Humeral Reconstruction&#xD;
      Prosthesis in shoulder arthroplasty over time. This study will follow subjects for a period&#xD;
      of up to 10 years post-surgery.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 5, 2018</start_date>
  <completion_date type="Anticipated">September 30, 2031</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Other</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>SST-12</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Shoulder Simple Test (SST) - 12 questions with yes/no responses that measure shoulder pain and function from a patient's perspective - 12 yes corresponds to 100%</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SPADI</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Shoulder Pain and Disability Index (SPADI) -13 questions assessing about pain scale (5 questions) and disability scale (8 questions) where 0 indicates no pain/no difficulty and 10 indicates worst pain imaginable/so difficult it requires help while performin these activities</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Constant</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Constant Shoulder Score - 100 points scale about pain, Activities of daily living, Strength test, and Range of Motions questions about shoulder where 100 % corresponds to the highest pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ASES</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>American Shoulder and Elbow Surgeons Score (ASES) - 100 points scale about shoulder pain and performance evaluation in activities of daily living where 100 indicates the best shoulder condition</description>
  </primary_outcome>
  <primary_outcome>
    <measure>UCLA</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>University of California Los Angeles Shoulder Score (UCLA) - 5 Items score which combines both physician (3 items) and patient assessment (2 items) whith a total range from 0-35 where 0 indicates worse shoulder function and 35 better shoulder function outcomes</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TESS</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Toronto Extremity Salvage Score (TESS) - Patient functional assessment following for surgery for musculoskeletal tumors (Humeral Reconstruction Stem only) - 100-point score where higher score indicates a better outcome</description>
  </primary_outcome>
  <primary_outcome>
    <measure>MSTS</measure>
    <time_frame>Through study completion, an average of 1 per year</time_frame>
    <description>Musculoskeletal Tumor Society (MSTS) - 30 points [6 times (range 0-5)], simple measure of the upper extremity function (Humeral Reconstruction Stem only) - The maximum corresponds to the best score</description>
  </primary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Osteoarthritis Shoulder</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Oncology</condition>
  <eligibility>
    <study_pop>
      <textblock>
        -  Patients who meet eligibility criteria&#xD;
&#xD;
          -  Patients who consent to participate to return for follow-up visits out to 10 years or&#xD;
             longer&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient is indicated for shoulder arthroplasty (or has previously undergone shoulder&#xD;
             arthroplasty)&#xD;
&#xD;
          -  Patient is at least 21 years of age&#xD;
&#xD;
          -  Patient is expected to survive at least 2 years beyond surgery&#xD;
&#xD;
          -  Patient is willing to participate by complying with pre- and postoperative visit&#xD;
             requirements&#xD;
&#xD;
          -  Patient is willing and able to read and sign a study informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Osteomyelitis of the proximal humerus or scapula; if a systemic infection or a&#xD;
             secondary remote infection is suspected or confirmed, implentation should be delayed&#xD;
             until infection is resolved&#xD;
&#xD;
          -  Inadequate or malformed bone that precludes adequate support or fixation of the&#xD;
             prosthesis&#xD;
&#xD;
          -  Neuromuscular disorders that do not allow control of the joint&#xD;
&#xD;
          -  SIgnigicant injury to the brachial plexus&#xD;
&#xD;
          -  Non-functional deltoid muscles&#xD;
&#xD;
          -  Patient's age, weight, or activity level would cause the surgeon to expect early&#xD;
             failure of the system&#xD;
&#xD;
          -  The patient is unwilling or unable to comply with the post-operative care instructions&#xD;
&#xD;
          -  Alcohol, drug, or other subtance abuse&#xD;
&#xD;
          -  Any disease state that could adversely affect the function or longevity of the implant&#xD;
&#xD;
          -  Patient is pregnant&#xD;
&#xD;
          -  Patient is a prisoner&#xD;
&#xD;
          -  Patient has a physical or mental condition that would invalidate the results&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rachael Craig</last_name>
    <phone>352-377-1140</phone>
    <email>rachael.craig@exac.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Sandrine Angibaud</last_name>
    <phone>352-2377-1140</phone>
    <email>sandrine.angibaud@exac.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Western Orthopaedics Research and Education Foundation</name>
      <address>
        <city>Denver</city>
        <state>Colorado</state>
        <zip>80218</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Libby Mauter</last_name>
      <phone>303-321-1333</phone>
    </contact>
    <investigator>
      <last_name>Armodios M Hatzidakis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2022</verification_date>
  <study_first_submitted>November 7, 2022</study_first_submitted>
  <study_first_submitted_qc>November 7, 2022</study_first_submitted_qc>
  <study_first_posted type="Actual">November 14, 2022</study_first_posted>
  <last_update_submitted>November 7, 2022</last_update_submitted>
  <last_update_submitted_qc>November 7, 2022</last_update_submitted_qc>
  <last_update_posted type="Actual">November 14, 2022</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

